Delivery Order SPE2DR25D1021-SPE2DR26FNL5S
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,824.50 to AmerisourceBergen Drug Corp for the supply of Gel-One 30 mg/3 mL syringes on July 30, 2025, with an ultimate completion date of August 20, 2025. This competitive contract award, which carries no set-aside designation, is structured as a firm fixed price delivery order. The product will be delivered to AmerisourceBergen's location in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and...
- The Defense Logistics Agency awarded a $1,094.70 firm fixed-price delivery order to AmerisourceBergen Drug Corp on October 30, 2025, for the supply of Gel-One 30 mg/3 mL syringes. This competitively awarded, non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The product will be performed and delivered from...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Gel-One 30 mg/3 mL syringes with a ceiling value of $5,473.50. This firm fixed price delivery order, with an ultimate completion date of September 12, 2025, represents a competitive award with no set-aside designation. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. As a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded a delivery order valued at $9,122.50 to AmerisourceBergen Drug Corp for Gel-One 30 mg/3 mL syringes (3 mL units) on September 23, 2025, with completion targeted for October 15, 2025. This is a firm fixed-price delivery order with no set-aside designation, meaning it was awarded through open competition. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Gel-One 30 mg/3 mL syringes with a ceiling value of $1,094.70. This is a firm fixed-price delivery order with an ultimate completion date of September 8, 2025, and represents a non-set-aside competitive award. The order will be fulfilled from AmerisourceBergen's location in Conshohocken, Pennsylvania, the company's corporate headquarters. This delivery order is issued...
- The Defense Logistics Agency awarded a $11.5K delivery order to AmerisourceBergen Drug Corp on October 31, 2025, for the supply of Gel-One 30 mg/3 ml syringes. This non-set-aside, competitively awarded contract employs firm fixed pricing and is scheduled for completion by November 24, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery order from its corporate office location in the same municipality....
- The Defense Logistics Agency awarded a delivery order valued at $5,473.50 to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Gel-One 30 mg/3 ml syringes. This competitive, firm fixed-price delivery order is scheduled for completion by September 15, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract carries no set-aside designation, indicating it was awarded through open competition. This delivery order is a child contract issued...
- The Defense Logistics Agency awarded a $21,894.00 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Gel-One 30 mg/3 mL syringes on September 24, 2025, with an ultimate completion date of October 16, 2025. This non-set-aside award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $1 billion and extending through December 2026. The product will be delivered to the company's corporate...
- The Defense Logistics Agency awarded a $36,490 delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Gel-One 30 mg/3 mL syringes under a firm fixed-price contract. The order is expected to be completed by October 17, 2025, with performance at AmerisourceBergen's location in Conshohocken, Pennsylvania. This is a non-set-aside award made through competitive procurement, reflecting AmerisourceBergen's established capability to meet federal medical supply...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,649.00 to AmerisourceBergen Drug Corp for the supply of Gel-One 30 mg/3 mL syringes. This firm fixed-price delivery order, issued on August 4, 2025, with an ultimate completion date of August 25, 2025, represents a competitive award with no set-aside designation. The product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. As a child order...
- SPE2DR25D1021Indefinite Delivery Contract
- SPE2DR25D1021-SPE2DR26FNL5SDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,845.50 to AmerisourceBergen Drug Corp for the supply of Gel-One 30 mg/3 mL syringes on October 28, 2025, with completion targeted for November 19, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters. This delivery order falls within AmerisourceBergen's comprehensive pharmaceutical and medical supply support mission for the federal government, particularly serving Defense Health Agency and military healthcare systems worldwide. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen maintains an extensive portfolio of pharmaceutical products and medical devices across multiple therapeutic domains. The parent IDC vehicle enables flexible procurement of pharmaceuticals, medical supplies, vaccines, and specialized healthcare commodities to support military operations and veteran healthcare needs globally, with the company demonstrating consistent capability to fulfill federal requirements through open competition on both small-value and substantial medical supply orders.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.8k | 10/28/25 |